The optimized formulation provides enhanced modulation of mitochondrial metabolism and fatty-acid oxidation. It also contributes to stronger regulation of inflammatory signaling pathways and improved mitochondrial adaptive responses.
Mechanism of action
ULTRA MOTS-c activates several key metabolic regulators involved in cellular energy control:
ULTRA MOTS-c → AMPK activation + PGC-1α activation + NRF2 activation
These pathways are associated with increased fatty-acid oxidation, improved mitochondrial function, enhanced insulin sensitivity, and reduced inflammatory signaling. Activation of AMPK and PGC-1α supports mitochondrial biogenesis and metabolic flexibility, allowing cells to use energy substrates more efficiently and adapt to physiological stress.
As a result, the peptide may contribute to improved metabolic performance, enhanced endurance capacity, and better cellular resilience under conditions of high physical or metabolic demand.
Mitochondrial peptides such as MOTS-c have become an important focus of research in metabolic health, performance optimization, and longevity science. Demand for mitochondrial-supporting peptides has increased significantly in recent years, particularly among individuals interested in improving energy balance, metabolic efficiency, and recovery.
Suggested protocol
Week 1–2
50–100 mcg per day, typically administered in the morning.
Week 3 and beyond
200–400 mcg per day depending on protocol requirements.
Administration method
Subcutaneous injection in the abdominal or thigh area.
Course duration
Approximately 30 days, commonly repeated several times per year within structured metabolic or performance programs.
ULTRA MOTS Pen is frequently incorporated into protocols focused on metabolic optimization, energy support, endurance improvement, and body-composition management. By supporting mitochondrial efficiency and cellular metabolic pathways, the peptide helps the body maintain stable energy production and adapt more effectively to physical and environmental stress.
